U.S. Stock Night Trading Opening Movements
Cisco rose 20.30% in night trading. Based on recent news,
<ol>
<li>
On May 14, Cisco announced its third-quarter results, with revenue of $15.8 billion, exceeding market expectations of $15.57 billion, and adjusted earnings per share of $1.06, better than the expected $1.04. The company also announced a restructuring plan that will lay off fewer than 4,000 employees. This news drove the stock price up more than 16% in extended trading hours.
</li>
<li>
On May 14, Cisco projected fourth-quarter revenue to be between $16.7 billion and $16.9 billion, exceeding analysts' expectations of $15.82 billion. The company also raised its full-year revenue forecast to between $62.8 billion and $63 billion, up from the previous expectation of $61.2 billion to $61.7 billion. This upward revision further boosted market confidence.
</li>
<li>
On May 14, Cisco announced that its product orders in the third quarter increased by 35% year-over-year, with growth across all regions and customer markets. Excluding orders from hyperscale cloud service providers, the year-over-year growth rate was 19%. This strong order growth indicates robust market demand for its products. Strong demand for AI infrastructure is driving growth in network equipment demand.
</li>
</ol>
Macrogenics rose 7.25% in night trading. Based on recent key news:
<ol>
<li>
On May 13, MacroGenics reported first-quarter revenue that exceeded expectations, reaching $20.8 million, surpassing analysts' estimate of $15.1 million, which drove the stock price up. Source: Reuters
</li>
<li>
On May 12, Boehringer Ingelheim announced the acquisition of MacroGenics' CDMO business for $122.5 million, which is expected to enhance its biopharmaceutical contract manufacturing capabilities and boost market confidence. Source: Zhitong Finance
</li>
<li>
On May 11, MacroGenics reached an agreement with Boehringer Ingelheim to sell its manufacturing business to Boehringer, and after the transaction is completed, it will continue to support its internal R&amp;D needs, further stabilizing the stock price. Source: MT Newswires The biopharmaceutical industry is growing rapidly, with strong market demand.
</li>
</ol>
Top Gainers in U.S. Stock Night Trading
Leslies rose 25.87% in night trading. Based on recent key news:
<ol>
<li>
On May 13, Leslie's released its second-quarter financial report, showing a 4.3% increase in sales, an 8% increase in customer numbers, and a 26% improvement in adjusted EBITDA. The company reaffirmed its full-year revenue guidance of $1.1 billion to $1.25 billion, driving the stock price up. Data source: SEC announcement.
</li>
<li>
On May 13, Leslie's announced strategic initiatives, including price reduction activities and operational efficiency improvements, which are expected to drive EBITDA improvement of $5 million to $10 million in fiscal year 2026. This move enhanced market confidence, and the stock price rose accordingly. Data source: Company press release
On May 13, analysts rated Leslie's as &#34;Hold,&#34; but Wall Street's 12-month target price is $2, which is 28.5% higher than the latest closing price. This positive market expectation further supports the rise in stock prices. Data source: Reuters analyst report. The retail industry has shown strong performance recently, with significant capital inflows.
</li>
</ol>
Innoviz Tech rose 13.48% in after-hours trading. Based on recent key news:
<ol>
<li>
On May 13, Innoviz signed a framework agreement with Kela Technologies to supply hundreds of InnovizTwo LiDAR sensors. This collaboration is expected to expand to thousands of units in the coming years, with the sensors being used for armored vehicles, border security, and perimeter defense tasks. This news drove the stock price up.
</li>
<li>
On May 13, Innoviz reached an agreement with an industry-leading company to assess the progress of upgraded sensor perception software. This agreement was signed in Tel Aviv, Israel, demonstrating ongoing development and collaboration in the field of autonomous driving technology, further boosting market confidence.
</li>
<li>
On May 13, Kela Technologies announced the development of an open modular platform to enhance military operational capabilities, and the collaboration with Innoviz marks a significant enhancement of military technology capabilities, increasing investor confidence in Innoviz. The field of autonomous driving technology continues to develop, and the market is active.
</li>
</ol>
Stubhub - CL rose 12.50% in after-hours trading. Based on recent key news:
<ol>
<li>
On May 13, StubHub announced its Q1 2026 financial report, showing a 7% year-over-year increase in total merchandise sales and a 12% year-over-year increase in revenue. This strong financial performance drove the stock price up. Source: Reuters
</li>
<li>
On May 13, StubHub announced a net income of $0.06 per share, reversing a loss of $0.12 per share in the same period last year. Analysts had expected $0.01 per share, exceeding market expectations and further boosting the stock price. Source: MT Newswires
</li>
<li>
On May 12, StubHub plans to participate in the JP Morgan Global Technology, Media, and Telecommunications Conference, where CEO Eric Baker will hold a fireside chat, and the market is optimistic about the company's future development. Source: Business Wire The live music market is growing steadily, with strong demand
</li>
</ol>

CSCO

MGNX

Cisco night trading rose 20.30%; Macrogenics night trading rose 7.25%; Leslies night trading rose 25.87%; Innoviz Tech night trading rose 13.48%; Stubhub - CL night trading rose 12.50%

Price Alert

Cisco

U.S. stock night trading opens with fluctuations: Cisco rises 20.30% in night trading; Macrogenics rises 7.25% in night trading